SLC31A1 and breast carcinoma: In addition, via a bioinformatic analysis, we found that relatively higher expression of CTR1 was associated with poor outcome of breast cancer patients (Figure 4d), indicating that CTR1 might serve as a potential prognosis marker for breast cancer.